Diabetic complications affecting the eyes, kidneys, and nerves are difficult to arrest once
in progress. Recent evidence that fenofibrate confers a robust yet unexpected benefit in
diabetic retinopathy offers an important translational research opportunity. The
investigator's global proteomic study will provide new clues as to how fenofibrate protects
vulnerable tissues, and will spur discovery of targets for new therapeutic interventions.